Ramucirumab’s Journey in India

Dear Dr. Renukaprasad A R, How does ramucirumab play a key role in advanced gastric cancer (GC) and epidermal growth factor receptor mutation-positive (EGFRm+) advanced non-small cell lung cancer (NSCLC) patients? Join this special webinar on 14th October 2022 at 07:30 PM IST with our distinguished oncologists, Dr. SVSS Prasad, Dr. Krupa Shankar, and Dr. Linu Jacob, as they discuss the clinical benefits of ramucirumab in GC and provide information that improves treatment decisions for EGFRm+ NSCLC patients. The experts will address your queries live in this Q&A-based session. We await your participation in this informative discussion. Session highlights: An overview of ramucirumab's journey in India - Dr. SVSS Prasad Ramucirumab in 2nd line gastric cancer with case discussion - Dr. Krupa Shankar Improve treatment decisions for EGFRm+ NSCLC - Dr. Linu Jacob Q&A with the experts: Tailor the treatment for gastric and EGFRm+ NSCLC patients Click to Know More   Add to Calendar Docplexus is one of the world's Largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*